Cargando…

Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in Human Liver Cells and Association with Hepatocellular Carcinoma

Published studies have identified genetic variants, somatic mutations, and changes in gene expression profiles that are associated with hepatocellular carcinoma (HCC), particularly involving genes that encode drug metabolizing enzymes (DMEs). CYP2C9, one of the most abundant and important DMEs, is i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dianke, Green, Bridgett, Marrone, April, Guo, Yongli, Kadlubar, Susan, Lin, Dongxin, Fuscoe, James, Pogribny, Igor, Ning, Baitang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336941/ https://www.ncbi.nlm.nih.gov/pubmed/25704921 http://dx.doi.org/10.1038/srep08534

Ejemplares similares

Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018)

Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway
por: Chen, Hui, et al.
Publicado: (2021)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation
por: Zheng, Tianying, et al.
Publicado: (2022)

NAIF1 suppresses osteosarcoma progression and is regulated by miR‐128
por: Kong, Daliang, et al.
Publicado: (2018)

Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2015)

MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
por: Petty, Robert D., et al.
Publicado: (2016)

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2020)

The Role of miR-128 in Neurodegenerative Diseases
por: Lanza, Marika, et al.
Publicado: (2023)

Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939
por: McDonald, Marguerite K., et al.
Publicado: (2016)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice
por: Tryndyak, Volodymyr P., et al.
Publicado: (2016)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2021)

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer
por: Zhang, Xuemei, et al.
Publicado: (2013)

MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met
por: Xu, Xin, et al.
Publicado: (2022)

hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma
por: Anwar, Sumadi Lukman, et al.
Publicado: (2017)

MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
por: Cao, Danxia, et al.
Publicado: (2020)

Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA
por: Luo, Yuan-Yuan, et al.
Publicado: (2022)

There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population
por: Ma, Fei, et al.
Publicado: (2013)

Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer
por: Weber, David, et al.
Publicado: (2018)

microRNA hsa-miR-425-5p and hsa-miR-4523 expressions as biomarkers of active pulmonary tuberculosis, latent tuberculosis infection, and lymph node tuberculosis
por: Massi, Muhammad Nasrum, et al.
Publicado: (2023)

MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma
por: Yang, Xiaohui, et al.
Publicado: (2020)

Role of miR-128 in hypertension-induced myocardial injury
por: Yin, Jie, et al.
Publicado: (2017)

Comparative Analysis, Structural Insights, and Substrate/Drug Interaction of CYP128A1 in Mycobacterium tuberculosis
por: Ngcobo, Nokwanda Samantha, et al.
Publicado: (2020)

Clinical significance of expression of hsa-mir-1247 and hsa-mir-1269a in ectopic pregnancy due to salpingitis
por: Zhang, Suxia, et al.
Publicado: (2018)

Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells
por: Chen, Hsin-An, et al.
Publicado: (2021)

MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1
por: Wu, Lan, et al.
Publicado: (2021)

Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622
por: Zou, Haibo, et al.
Publicado: (2019)

Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma
por: Jiang, Zhenluo, et al.
Publicado: (2019)

hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP
por: Liang, Jian, et al.
Publicado: (2021)

Circular RNA hsa_circ_0004543 Aggravates Cervical Cancer Development by Sponging MicroRNA hsa-miR-217 to Upregulate Hypoxia-Inducible Factor
por: Liu, Jun, et al.
Publicado: (2022)

“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
por: Bertero, Thomas, et al.
Publicado: (2012)

Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
por: Yang, Liu, et al.
Publicado: (2018)

microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2014)

Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration
por: Huang, Wei, et al.
Publicado: (2018)

MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy
por: Avansini, Simoni H., et al.
Publicado: (2017)

MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
por: Li, Lei, et al.
Publicado: (2020)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma
por: Jiang, Peiqiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uh8d16p7g2l2iojrd8c430r5vs